Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Vincerx Pharma, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 26 | −1 |
| Shares | 10.7M | 47.1K | 11.0M | +369.6K (+3.5%) |
| Value | $8.66M | $38.1K | $7.89M | −$734.4K (−8.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Vincerx Pharma, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 47,080 | $33.7K | 0.00% |
| Susquehanna International Group, LLP | 31,980 | $22.9K | 0.00% |
| Jane Street Group, LLC | 20,905 | $15.0K | 0.00% |
| HRT Financial LP | 14,701 | $10.0K | 0.00% |
| JPMorgan Chase & Co | 58 | $42 | 0.00% |
Sold out (6)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Citadel Advisors LLC | 178,240 | $144.4K |
| Millennium Management LLC | 11,445 | $9.27K |
| LPL Financial LLC | 10,270 | $8.32K |
| LMR Partners LLP | 10,000 | $8.10K |
| Colony Group, LLC | 10,900 | $8.00K |
| Qube Research & Technologies Ltd | 4 | $4 |
Not filed for Q3 2024 yet (1)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 47,080 | $38.1K |